LLMpediaThe first transparent, open encyclopedia generated by LLMs

Eliminate Dengue

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: dengue fever Hop 4
Expansion Funnel Raw 66 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted66
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Eliminate Dengue
NameEliminate Dengue
Formation2004
FounderScott O'Neill, Peter McCallum
TypeResearch consortium
LocationMonash University, Townsville
FocusVector control, infectious disease, public health

Eliminate Dengue is a scientific research program and public health initiative originating from Monash University and collaborating institutions to reduce transmission of dengue fever through innovative vector control strategies. The program developed and deployed a Wolbachia-based approach targeting Aedes aegypti to interrupt transmission chains of dengue virus, with partnerships spanning universities, public health agencies, and municipal authorities. Its work has informed policy debates in Australia, Indonesia, Brazil, and other dengue-endemic regions, influencing guidelines from agencies and researchers worldwide.

Overview

The program was established as a collaborative effort among academic institutions such as Monash University, University of Queensland, and research institutes like the World Mosquito Program and the Australian Defence Force research facilities, engaging with municipal bodies including Townsville City Council and national ministries such as the Indonesian Ministry of Health and Brazilian Ministry of Health. Founders and principal investigators drew on prior entomological and virological research by figures associated with CSIRO and international collaborations with groups linked to World Health Organization technical networks and the Bill & Melinda Gates Foundation funding ecosystem. The initiative integrated expertise from laboratories at QIMR Berghofer Medical Research Institute, field teams modeled on practices from Centers for Disease Control and Prevention, and ethical frameworks referenced in guidance from the National Health and Medical Research Council.

History and Development

Origins trace to academic work on symbiotic bacteria led by researchers connected to Monash University and collaborations with entomologists from James Cook University and virologists tied to Walter Reed Army Institute of Research. Early milestones involved laboratory demonstrations at facilities related to Australian National University and pilot studies informed by vector control history including campaigns like those associated with Pan American Health Organization programs. Key scientific contributors include investigators with links to institutions like University of Oxford, Harvard University, and University of California, Davis, whose prior work on insect microbe interactions and arbovirus ecology influenced protocol development. International partnerships expanded to include research teams in Indonesia, Vietnam, Colombia, and Brazil, aligning with regional public health strategies shaped by entities such as PAHO and national research councils.

Wolbachia-Based Intervention Method

The intervention centers on introduction of maternally inherited Wolbachia pipientis strains into populations of Aedes aegypti to reduce vector competence for dengue virus and related arboviruses like Zika virus and chikungunya virus. Laboratory studies at institutes including QIMR Berghofer, Monash University, and collaborators in Indonesia tested cytoplasmic incompatibility dynamics first characterized in research by investigators from University of Cambridge and Max Planck Institute groups. Release strategies drew upon modelling from computational groups affiliated with Imperial College London and population genetics frameworks developed by researchers at University of Edinburgh and Stanford University. Quality control and rearing protocols referenced insectary practices from Centers for Disease Control and Prevention and entomological standards used by World Health Organization vector research units.

Field Trials and Implementation

Field releases took place in urban and peri-urban sites including Townsville, Yogyakarta, Niterói, and locations in Indonesia and Brazil, under operational plans coordinated with local health secretariats and municipal authorities such as Yogyakarta City Government and Niterói City Hall. Implementation involved community engagement models drawing on experience from public health campaigns run by Médecins Sans Frontières and immunization outreach methods used by UNICEF, with ethical review processes involving committees associated with Monash University Human Research Ethics Committee and national regulatory bodies like ANVISA in Brazil. Deployment logistics leveraged entomological mapping techniques practiced at James Cook University and monitoring frameworks developed in collaboration with Australian Institute of Tropical Health and Medicine.

Efficacy and Impact Studies

Assessment of impacts has been reported in peer-reviewed publications led by researchers affiliated with Monash University, University of Queensland, Imperial College London, and Universidade Federal do Rio de Janeiro, using randomized controlled trial designs and quasi-experimental analyses similar to those used in vaccine trials overseen by National Institutes of Health. Results indicated reductions in dengue incidence in intervention areas, corroborated by serological surveillance methods utilized by laboratories connected to Walter Reed Army Institute of Research and analytical approaches used in Johns Hopkins University public health studies. Meta-analyses and modeling work by teams linked to London School of Hygiene & Tropical Medicine and University of Melbourne explored long-term transmission dynamics and cost-effectiveness alongside evaluations from World Health Organization technical consultations.

Regulatory, Ethical, and Community Engagement Issues

Regulatory review processes involved agencies such as Australian Pesticides and Veterinary Medicines Authority, ANVISA, and national biosafety committees in Indonesia and Brazil, with policy input from advisers connected to World Health Organization Expert Advisory Panels. Ethical considerations drew upon frameworks advanced at Monash University and debated in forums including conferences of the International Association for Public Health Institutes and symposia at Harvard T.H. Chan School of Public Health. Community engagement strategies referenced public consultation models from WHO guidance and participatory methods used by UNICEF and civil society organizations like Health Consumer Alliance-type groups to secure local acceptance and informed consent.

Challenges and Future Directions

Ongoing challenges include scalability across megacities like São Paulo and Jakarta, integration with complementary strategies such as novel insecticides overseen by teams at Liverpool School of Tropical Medicine, and surveillance across borders involving agencies like PAHO and ASEAN health partners. Research priorities involve strain selection questions studied by molecular groups at Max Planck Institute for Infection Biology and evolutionary dynamics explored by teams at Scripps Research Institute and Cold Spring Harbor Laboratory. Future directions emphasize partnerships with philanthropic funders such as Bill & Melinda Gates Foundation and multilateral organizations including World Health Organization to expand trial networks and policy uptake in endemic regions.

Category:Public health initiatives